Modulation of post-pacing action potential duration and contractile responses on ventricular arrhythmogenesis in chloroquine-induced long QT syndrome

被引:2
|
作者
Liu, Chih-Min [1 ,2 ]
Lin, Fong-Jhih [3 ,4 ]
Chen, Yao-Chang [4 ]
Lin, Yung-Kuo [5 ,6 ]
Lu, Yen-Yu [7 ]
Chan, Chao-Shun [6 ]
Higa, Satoshi [8 ]
Chen, Shih-Ann [1 ,2 ,9 ,10 ]
Chen, Yi-Jen [3 ,5 ,11 ]
机构
[1] Taipei Vet Gen Hosp, Heart Rhythm Ctr, Dept Med, Div Cardiol, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[3] Taipei Med Univ, Grad Inst Clin Med, Coll Med, 250 Wu Hsing St, Taipei, Taiwan
[4] Natl Def Med Ctr, Dept Biomed Engn, Taipei, Taiwan
[5] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Cardiovasc Med, Taipei, Taiwan
[6] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan
[7] Sijhih Cathay Gen Hosp, Div Cardiol, New Taipei, Taiwan
[8] Makiminato Cent Hosp, Div Cardiovasc Med, Cardiac Electrophysiol & Pacing Lab, Onna, Okinawa, Japan
[9] Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan
[10] Natl Chung Hsing Univ, Taichung, Taiwan
[11] Taipei Med Univ, Wan Fang Hosp, Cardiovasc Res Ctr, Taipei, Taiwan
关键词
Excitation -contraction coupling; Long QT; Magnesium; Na + -Ca 2+exchanger inhibitor; Ranolazine; Ventricular arrhythmias; MAGNESIUM; ARRHYTHMIAS; RANOLAZINE; TRACT;
D O I
10.1016/j.ejphar.2023.175493
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Excitation-contraction (E-C) coupling, the interaction of action potential duration (APD) and contractility, plays an essential role in arrhythmogenesis. We aimed to investigate the arrhythmogenic role of E-C coupling in the right ventricular outflow tract (RVOT) in the chloroquine-induced long QT syndrome. Methods: Conventional microelectrodes were used to record electrical and mechanical activity simultaneously under electrical pacing (cycle lengths from 1000-100 ms) in rabbit RVOT tissue preparations before and after chloroquine with and without azithromycin. KB-R7943 (a Na+-Ca2+ exchanger [NCX] inhibitor), ranolazine (a late sodium current inhibitor), or MgSO4 were used to assess their pharmacological responses in the chloroquineinduced long QT syndrome. Results: Sequential infusion of chloroquine and chloroquine plus azithromycin triggered ventricular tachycardia (VT) (33.7%) after rapid pacing compared to baseline (6.7%, p = 0.004). There were greater post-pacing increases of the first occurrence of contractility (AContractility) in the VT group (VT vs. non-VT: 521.2 +/- 50.5% vs. 306.5 +/- 26.8%, p < 0.001). There was no difference in the first occurrence of action potential at 90% repolarization (AAPD90) (VT vs. non-VT: 49.7 +/- 7.4 ms vs. 51.8 +/- 13.1 ms, p = 0.914). Pacing-induced VT could be suppressed to baseline levels by KB-R7943 or MgSO4. Ranolazine did not suppress pacing-induced VT in chloroquine-treated RVOT. AContractility was reduced by KB-R7943 and MgSO4, but not by ranolazine. Conclusion: AContractility (but not AAPD) played a crucial role in the genesis of pacing-induced VT in the long QT tissue model, which can be modulated by NCX (but not late sodium current) inhibition or MgSO4.
引用
收藏
页数:8
相关论文
共 28 条
  • [21] Gender and Regional Differences in Ical Distribution in Adult Rabbit Right Ventricle Influence Action Potential Duration and the Propensity for Eads in a Model of Long QT Syndrome Type 2
    Doinoff, Cassandra M.
    Kalik, Zane M.
    Wright, Moriah E.
    Jalics, Jozsi Z.
    Sims, Carl
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 530A - 530A
  • [22] SGK1 Inhibition Attenuated the Action Potential Duration In-Patient and Genotype-Specific Re-Engineered Heart Cells With Congenital Long QT Syndrome
    Tester, David J.
    Das, Saumya
    Kim, Maengjo
    Pradhananga, Sabindra
    Hamrick, Samantha K.
    Srinivasan, Dinesh
    Sager, Philip
    Ackerman, Michael J.
    CIRCULATION, 2022, 146
  • [23] Sodium/Glucose Co-Transporter 2 Inhibition and Attenuation of the Action Potential Duration in Patient-Specific Re-Engineered Heart Cells With Congenital Long QT Syndrome
    Zhou, Wei
    Kim, Maengjo
    Tester, David J.
    Giudicessi, John
    Ackerman, Michael J.
    CIRCULATION, 2022, 146
  • [24] The Novel Late Sodium Current Blocker GS-458967 Suppresses Action Potential Duration Alternans and Early Afterdepolarization in a Transgenic Rabbit Model of Long Qt Syndrome Type 2
    Hwang, Jungmin
    Belardinelli, Luiz
    Rajamani, Sridharan
    Pfeiffer, Zachary
    Yang, Bryant
    Kim, Taeyun
    Centracchio, Jason
    Schofield, Lorraine
    Peng, Xuwen
    Kodssidas, Konstantinos
    Koren, Gideon
    Choi, Bum Rak
    CIRCULATION, 2012, 126 (21)
  • [25] Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
    Lan, Huan
    Xu, Qiang
    El-Battrawy, Ibrahim
    Zhong, Rujia
    Li, Xin
    Lang, Siegfried
    Cyganek, Lukas
    Borggrefe, Martin
    Zhou, Xiaobo
    Akin, Ibrahim
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [26] Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K plus channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells
    Jehle, J.
    Ficker, E.
    Wan, X.
    Deschenes, I.
    Kisselbach, J.
    Wiedmann, F.
    Staudacher, I.
    Schmidt, C.
    Schweizer, P. A.
    Becker, R.
    Katus, H. A.
    Thomas, D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (05) : 1215 - 1229
  • [27] SGK1 inhibition normalizes action potential duration in transgenic LQT2 rabbits but not in LQT1, suggesting a novel gene-specific therapeutic approach in long QT syndrome
    Barbieri, M.
    Lourdaour, J.
    Alerni, N.
    Giammarino, L.
    Nimani, S.
    Matas, L.
    Horvath, A.
    Odening, K. E.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [28] Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation
    Estes, Steven, I
    Ye, Dan
    Zhou, Wei
    Dotzler, Steven M.
    Tester, David J.
    Bos, J. Martijn
    Kim, C. S. John
    Ackerman, Michael J.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2019, 12 (08): : e002534